PMV Pharmaceuticals, Inc. (PMVP)

PMV Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48.48	38.53	109.12	173.29	361.42	73.28
Short-Term Investments	150.29	165.35	132.76	124.7	0	28.21
Cash & Cash Equivalents	198.76	203.88	241.88	297.99	361.42	101.49
Cash Growth	-13.68%	-15.71%	-18.83%	-17.55%	256.13%	63.93%
Other Current Assets	3.7	3.53	5.13	3.3	3.34	0.61
Total Current Assets	202.46	207.41	247.01	301.29	364.76	102.09
Property, Plant & Equipment	19.11	19.05	20.49	13.15	0.57	0.74
Long-Term Investments	15.12	25.51	2.5	16.91	0	0
Other Long-Term Assets	0.18	0.19	0.31	0.22	0.2	0.2
Total Long-Term Assets	34.42	44.74	23.3	30.28	0.77	0.94
Total Assets	236.88	252.15	270.31	331.57	365.53	103.03
Accounts Payable	0.86	3.24	3	3.19	1.61	2.84
Current Debt	0.88	0.85	0.53	0.4	0	0
Other Current Liabilities	10.32	9.94	7.31	8.63	4.8	1.69
Total Current Liabilities	12.06	14.03	10.83	12.22	6.41	4.52
Long-Term Debt	12.14	12.43	13.45	10.79	0	0
Other Long-Term Liabilities	0	0	0	0	0	0.05
Total Long-Term Liabilities	12.14	12.43	13.45	10.79	0	0.05
Total Liabilities	24.2	26.46	24.28	23.01	6.41	4.57
Total Debt	13.02	13.29	13.98	11.19	0	0
Debt Growth	-3.38%	-4.94%	24.86%	-	-	-
Retained Earnings	-325.27	-310	-241.04	-167.73	-109.88	-75.44
Comprehensive Income	-0.13	0.22	-0.45	-0.08	0	-0
Shareholders' Equity	212.68	225.69	246.03	308.56	359.12	-70.47
Net Cash / Debt	185.74	190.59	227.9	286.79	361.42	101.49
Net Cash / Debt Growth	-14.32%	-16.37%	-20.53%	-20.65%	256.13%	63.93%
Net Cash Per Share	3.61	3.97	5.00	6.35	25.16	33.44
Working Capital	190.4	193.38	236.17	289.07	358.35	97.57
Book Value Per Share	4.13	4.70	5.40	6.84	25.00	-23.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).